CVE-2024-50374: advantech eki-6333ac-1gpo_firmware OS Command Injection
Vulnerability summary
CVE-2024-50374 is a critical (CVSS 9.8) OS Command Injection vulnerability in advantech eki-6333ac-1gpo_firmware. EPSS estimates a 1.47% chance of exploitation in the next 30 days, higher than 73.5% of scored vulnerabilities.
Timeline
- 26-11-2024PublishedVulnerability first disclosed.
- 26-11-2024Last modifiedVulnerability information updated.
Description
A CWE-78 "Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection')" was discovered affecting the following devices manufactured by Advantech: EKI-6333AC-2G (<= 1.6.3), EKI-6333AC-2GD (<= v1.6.3) and EKI-6333AC-1GPO (<= v1.2.1). The vulnerability can be exploited by remote unauthenticated users capable of interacting with the default "edgserver" service enabled on the access point and malicious commands are executed with root privileges. No authentication is enabled on the service and the source of the vulnerability resides in processing code associated to the "capture_packages" operation.
CVSS metrics
2 scores · 2 sources · 1 version- NVDNIST9.8CriticalCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
EPSS trend
Probability
1.47%
Chance of exploitation in the next 30 days
Percentile
74%
Versus all other CVEs
30-day change
0.00 pp
From 1.47% on 21-09-2026
Known exploited
Compare KEV catalogsNot in any of the 3 tracked catalogs.
Public exploits
0 foundNo public exploits indexed.
Weaknesses
CWE · root causeAffected systems
Advantech3 products
- eki-6333ac-1gpo_firmware≤ <= 1.2.1 | < 1.2.2
- eki-6333ac-2g_firmware≤ <= 1.6.3 | < 1.6.5
- eki-6333ac-2gd_firmware≤ <= 1.6.3 | < 1.6.5
1 vendor · 3 products
References
1 links- www.nozominetworks.com/labs/vulnerability-advisories-cve-2024-50374Third Party Advisory